Heart Failure

Heart Failure

The prevalence of heart failure (HF) continues to increase over time1 and affects >60 million people each year2.

Therefore, being aware of the latest data in the HF space and different treatment options is important in order to be able to apply findings to clinical practice when making treatment decisions for patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease, especially HF.

This section is supported by a grant from the Boehringer Ingelheim & Eli Lilly and Company Alliance

Boehringer Ingelheim

Content on this section was partly provided by Boehringer Ingelheim. For any follow up questions please contact your local Boehringer Ingelheim representative.

Clinical Case Study

Press Announcements

Study Design

1.Heart disease and stroke statistics-2020 update: a report from the American Heart Association

Virani SS, Alonso A, Benjamin EJ, et al. Circulation 2020;141:e139-e596.

https://doi.org/10.1161/CIR.0000000000000757

2. Global, regional, and national incidence, prevalence, and years lived with disability for 328 diseases and injuries for 195 countries, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016

GBD 2016 Disease and Injury Incidence and Prevalence Collaborators. Lancet 2017;390:1211-59.

https://doi.org/10.1016/S0140-6736(17)32154-2

Emerging Cardiac Resynchronisation Therapy Indications

Cardiac resynchronisation therapy (CRT) is an established therapy for patients with drug-refractory, highly symptomatic systolic heart failure (HF) and delayed ventricular conduction.1 CRT devices are designed to synchronise the mechanical activity within the left ventricle, between the left and the right ventricle and between the atria and ventricles.

Beyond the Apnea-Hypopnea Index - Prognostic Value of Other Elements of Polysomnography to Describe Sleep-disordered Breathing in Heart Failure

A growing appreciation of the prevalence of sleep breathing disorders, especially as comorbidities of disease syndromes such as chronic heart failure, has increased interest in screening, diagnosis, and treatment of obstructive and central sleep apnea. Sleep apnea diagnosis currently requires an overnight polysomnograhic evaluation in which the disease is defined as the number of times per hour that respiration is inadequate to maintain oxygen saturation.

Pages

Subscribe to RSS - Heart Failure